Enveric Biosciences secures a U.S. patent for non-hallucinogenic mescaline derivatives targeting addiction, ADHD and anxiety.
A politician in New York state has proposed a ban on what he describes as a "highly addictive substance". The move comes even ...
Outside of the technology arena, one of the best places to find growth stocks tends to be in the consumer goods space. This ...